BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1482761)

  • 21. Adrenal steroid receptors in the PVN: studies with steroid antagonists in relation to macronutrient intake.
    Tempel DL; McEwen BS; Leibowitz SF
    Neuroendocrinology; 1993 Jun; 57(6):1106-13. PubMed ID: 8232767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
    Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
    Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of neuropeptide Y microinjected into the hypothalamus on ethanol consumption.
    Lucas LA; McMillen BA
    Peptides; 2004 Dec; 25(12):2139-45. PubMed ID: 15572203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism.
    Morgan DG; Small CJ; Abusnana S; Turton M; Gunn I; Heath M; Rossi M; Goldstone AP; O'Shea D; Meeran K; Ghatei M; Smith DM; Bloom S
    Regul Pept; 1998 Sep; 75-76():377-82. PubMed ID: 9802432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient.
    Currie PJ; Coscina DV; Bishop C; Coiro CD; Koob GF; Rivier J; Vale W
    Brain Res; 2001 Oct; 916(1-2):222-8. PubMed ID: 11597609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diurnal variations in the feeding responses to norepinephrine, neuropeptide Y and galanin in the PVN.
    Tempel DL; Leibowitz SF
    Brain Res Bull; 1990 Dec; 25(6):821-5. PubMed ID: 1705161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism.
    Billington CJ; Briggs JE; Harker S; Grace M; Levine AS
    Am J Physiol; 1994 Jun; 266(6 Pt 2):R1765-70. PubMed ID: 8024026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT(2A/2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY-stimulated eating.
    Currie PJ; Saxena N; Tu AY
    Neuroreport; 1999 Sep; 10(14):3033-6. PubMed ID: 10549818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro.
    Pronchuk N; Colmers WF
    Br J Pharmacol; 2004 Mar; 141(6):1032-6. PubMed ID: 14967739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
    Dube MG; Kalra SP; Kalra PS
    Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional hypothalamic differences in neuropeptide Y-induced feeding and energy substrate utilization.
    Currie PJ; Coscina DV
    Brain Res; 1996 Oct; 737(1-2):238-42. PubMed ID: 8930371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPY receptors and opioidergic system are involved in NPY-induced feeding in goldfish.
    de Pedro N; López-Patiño MA; Guijarro AI; Pinillos ML; Delgado MJ; Alonso-Bedate M
    Peptides; 2000 Oct; 21(10):1495-502. PubMed ID: 11068096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y.
    Heinrichs SC; Menzaghi F; Pich EM; Hauger RL; Koob GF
    Brain Res; 1993 May; 611(1):18-24. PubMed ID: 8518948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis.
    Pu S; Jain MR; Horvath TL; Diano S; Kalra PS; Kalra SP
    Endocrinology; 1999 Feb; 140(2):933-40. PubMed ID: 9927326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y acts in the paraventricular nucleus to suppress sympathetic nerve activity and its baroreflex regulation.
    Cassaglia PA; Shi Z; Li B; Reis WL; Clute-Reinig NM; Stern JE; Brooks VL
    J Physiol; 2014 Apr; 592(7):1655-75. PubMed ID: 24535439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid changes in hypothalamic neuropeptide Y produced by carbohydrate-rich meals that enhance corticosterone and glucose levels.
    Wang J; Dourmashkin JT; Yun R; Leibowitz SF
    Brain Res; 1999 Nov; 848(1-2):124-36. PubMed ID: 10612704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin increases sympathetic nerve activity in part by suppression of tonic inhibitory neuropeptide Y inputs into the paraventricular nucleus in female rats.
    Cassaglia PA; Shi Z; Brooks VL
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R97-R103. PubMed ID: 27122366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus.
    Bonavera JJ; Dube MG; Kalra PS; Kalra SP
    Endocrinology; 1994 Jun; 134(6):2367-70. PubMed ID: 8194462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meal patterns and macronutrient intake after peripheral and PVN injections of the alpha 2-receptor antagonist idazoxan.
    Alexander JT; Cheung WK; Dietz CB; Leibowitz SF
    Physiol Behav; 1993 Apr; 53(4):623-30. PubMed ID: 8099748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.